off-target effects
Unintended genetic modifications at sites other than the intended target during gene editing.
As defined in 394 - Bringing Back The Mammoth
Where it comes up · 4
- Argenx: Changing Lives with Llamas4 claims
- 394 - Bringing Back The Mammoth1 claim
- 77 - The Moral Complexity Of Genetics1 claim
- 357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics1 claim
Most important claims · 7 of 7Search all claims for “off-target effects” →
- Many drugs treat one condition while damaging another through off-target interactions, so side effects make patients refuse treatments, and Argenx prioritizes minimizing off-target effects.Argenx: Changing Lives with Llamas
- Colossal uses a combination of editing tools—single-nucleotide base edits, gene knockouts, and synthesizing and inserting large DNA blocks to reduce off-target effects—but its key differentiator is pioneering multiplex editing, making many edits (20, 50, a thousand) across the genome simultaneously with high efficiency, since whole-chromosome synthesis is not yet possible.394 - Bringing Back The Mammoth
- CRISPR-Cas9, derived from an ancient bacterial defense system that chops up viral genomes, has been redesigned and reprogrammed to make intentional, targeted cuts at a chosen location in a genome and—combined with other techniques—to replace specific DNA letters, giving an unprecedented and programmable power to manipulate genomes, including potentially the human germline.77 - The Moral Complexity Of Genetics
- Combining CRISPR targeting with base editing and encoding the editor as mRNA allows an in vivo correction of a single DNA letter; because the mRNA is then destroyed, the editing machinery does not persist and cannot wander to cause off-target changes.357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics
- Because healthy antibodies also need recycling, Argenx's drug must be precise: overdoing the blockade could cause infections, but the company has managed to block only pathogenic recycling and keep immune function intact.Argenx: Changing Lives with Llamas
- Argenx's competitive strength is a patient-first strategy covering efficacy, safety, and convenience, which Julia argues is the company's main differentiator and leads to higher investment returns.Argenx: Changing Lives with Llamas
- Early data from competitor drugs on the same target show a large safety gap versus Argenx's drug, which Julia argues is a key differentiator.Argenx: Changing Lives with Llamas